doxorubicin-peptide-PEG conjugate (Watson)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namedoxorubicin-peptide-PEG conjugate (Watson)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionVirus DNA polymerase inhibitorsTopoisomerase II inhibitorsDNA intercalators
TargetsTopoisomerase IIVirus DNA polymeraseDNA
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActavis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActavis Inc
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A